Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

2225.82 (Glytoucan)

Id:c71cae1d-c188-54ee-baf2-de06d0df7b0e

Glytoucan:G55092AK

Results found

Linked to

	Label	Description
	2225.82 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000023 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2225.82 has glycosequence GLYGEN.GLYCOSEQUENCE:G66247AR-GLYCOSEQ00038299 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2225.82 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000056 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2225.82 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000002 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2225.82 has glycosequence GLYGEN.GLYCOSEQUENCE:G85217XJ-GLYCOSEQ00081007 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2225.82 has glycosequence GLYGEN.GLYCOSEQUENCE:G05450AP-GLYCOSEQ00106141 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2225.82 has canonical residue n-glycan core b-d-manp c Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2225.82 has glycosequence GLYGEN.GLYCOSEQUENCE:G28493ST-GLYCOSEQ00067903 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2225.82 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000006 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2225.82 has glycosequence GLYGEN.GLYCOSEQUENCE:G13757MF-GLYCOSEQ00175291 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2225.82 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000023 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2225.82 has glycosequence GLYGEN.GLYCOSEQUENCE:G66247AR-GLYCOSEQ00038299 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2225.82 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000056 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2225.82 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000002 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2225.82 has glycosequence GLYGEN.GLYCOSEQUENCE:G85217XJ-GLYCOSEQ00081007 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2225.82 has glycosequence GLYGEN.GLYCOSEQUENCE:G05450AP-GLYCOSEQ00106141 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2225.82 has canonical residue n-glycan core b-d-manp c

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2225.82 has glycosequence GLYGEN.GLYCOSEQUENCE:G28493ST-GLYCOSEQ00067903 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2225.82 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000006 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2225.82 has glycosequence GLYGEN.GLYCOSEQUENCE:G13757MF-GLYCOSEQ00175291 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.